Explore more publications!
Health Insider Virgin Islands
Got News to Share?

Health Insider Virgin Islands: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Insider Virgin Islands.

October 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

December 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30 31

Press releases published on October 1, 2025

Spur Therapeutics to Present New Clinical Data on Its Gene Therapy Candidate in Gaucher Disease at Upcoming ESGCT Annual Congress
October 1, 2025

Spur Therapeutics to Present New Clinical Data on Its Gene Therapy Candidate in Gaucher Disease at Upcoming ESGCT Annual Congress

Indeterminate GlobeNewswire
Arvinas to Present Clinical Data for ARV-102, a PROTAC LRRK2 Degrader, at the 2025 International Congress of Parkinson’s Disease and Movement Disorders®
October 1, 2025

Arvinas to Present Clinical Data for ARV-102, a PROTAC LRRK2 Degrader, at the 2025 International Congress of Parkinson’s Disease and Movement Disorders®

Indeterminate GlobeNewswire
Immatics Appoints Venkat Ramanan as Chief Financial Officer
October 1, 2025

Immatics Appoints Venkat Ramanan as Chief Financial Officer

Indeterminate GlobeNewswire
e-therapeutics Relaunches as Tangram Therapeutics and Unveils LLibra OS
October 1, 2025

e-therapeutics Relaunches as Tangram Therapeutics and Unveils LLibra OS

Indeterminate GlobeNewswire
Biomea Fusion, Inc. Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
October 1, 2025

Biomea Fusion, Inc. Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Neumora Therapeutics to Host Virtual R&D Day on October 27
October 1, 2025

Neumora Therapeutics to Host Virtual R&D Day on October 27

Indeterminate GlobeNewswire
Accumulus Synergy Appoints Khushboo Sharma as Chief Executive Officer
October 1, 2025

Accumulus Synergy Appoints Khushboo Sharma as Chief Executive Officer

Indeterminate GlobeNewswire
Accumulus Synergy nomme Khushboo Sharma au poste de Chief Executive Officer
October 1, 2025

Accumulus Synergy nomme Khushboo Sharma au poste de Chief Executive Officer

Indeterminate GlobeNewswire
Sagimet Biosciences Announces Dosing of First Participants in Phase 1 PK Clinical Trial for Denifanstat and Resmetirom Combination
October 1, 2025

Sagimet Biosciences Announces Dosing of First Participants in Phase 1 PK Clinical Trial for Denifanstat and Resmetirom Combination

Indeterminate GlobeNewswire
C4 Therapeutics Announces Clinical Trial Collaboration and Supply Agreement with Pfizer for the Combination of Cemsidomide and Elranatamab for the Treatment of Relapsed/Refractory Multiple Myeloma
October 1, 2025

C4 Therapeutics Announces Clinical Trial Collaboration and Supply Agreement with Pfizer for the Combination of Cemsidomide and Elranatamab for the Treatment of Relapsed/Refractory Multiple Myeloma

Indeterminate GlobeNewswire
Multiple Myeloma Research Foundation Unites Patients and Advocates to Hike New Hampshire’s White Mountains to Accelerate a Cure for Multiple Myeloma
October 1, 2025

Multiple Myeloma Research Foundation Unites Patients and Advocates to Hike New Hampshire’s White Mountains to Accelerate a Cure for Multiple Myeloma

Indeterminate GlobeNewswire
Accumulus Synergy ernennt Khushboo Sharma zur Chief Executive Officer
October 1, 2025

Accumulus Synergy ernennt Khushboo Sharma zur Chief Executive Officer

Indeterminate GlobeNewswire
Urticaria Day: Raising Awareness of Symptoms and Treatment
October 1, 2025

Urticaria Day: Raising Awareness of Symptoms and Treatment

Indeterminate GlobeNewswire
Verano Secures US $75,000,000 Revolving Credit Facility
October 1, 2025

Verano Secures US $75,000,000 Revolving Credit Facility

Indeterminate GlobeNewswire
Medicenna Therapeutics to Participate in the ROTH 4th Annual Healthcare Opportunities Conference
October 1, 2025

Medicenna Therapeutics to Participate in the ROTH 4th Annual Healthcare Opportunities Conference

Indeterminate GlobeNewswire
RetinalGenix Technologies and RGEN Clinical Genotyping Laboratory Announce Strategic Collaboration to Advance Early Detection of Neurodegenerative, Systemic, and Retinal Diseases
October 1, 2025

RetinalGenix Technologies and RGEN Clinical Genotyping Laboratory Announce Strategic Collaboration to Advance Early Detection of Neurodegenerative, Systemic, and Retinal Diseases

Indeterminate GlobeNewswire
Tessellate Bio Appoints Katie Chapman as Chief Scientific Officer
October 1, 2025

Tessellate Bio Appoints Katie Chapman as Chief Scientific Officer

Indeterminate GlobeNewswire
Inventiva Appoints Andrew Obenshain as Chief Executive Officer
October 1, 2025

Inventiva Appoints Andrew Obenshain as Chief Executive Officer

Indeterminate GlobeNewswire
90% Survey Participants Believe AI Has the Potential to Help Doctors Make Better Decisions
October 1, 2025

90% Survey Participants Believe AI Has the Potential to Help Doctors Make Better Decisions

Indeterminate GlobeNewswire

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions